Bio Uv Group Stock Cash And Equivalents
| ALTUV Stock | 2.13 0.05 2.40% |
BIO UV Group fundamentals help investors to digest information that contributes to BIO UV's financial success or failures. It also enables traders to predict the movement of BIO Stock. The fundamental analysis module provides a way to measure BIO UV's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIO UV stock.
BIO |
BIO UV Group Company Cash And Equivalents Analysis
BIO UV's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current BIO UV Cash And Equivalents | 361.07 K |
Most of BIO UV's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIO UV Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, BIO UV Group has 361.07 K in Cash And Equivalents. This is 99.91% lower than that of the Industrials sector and 99.36% lower than that of the Waste Management industry. The cash and equivalents for all France stocks is 99.99% higher than that of the company.
BIO Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIO UV's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIO UV could also be used in its relative valuation, which is a method of valuing BIO UV by comparing valuation metrics of similar companies.BIO UV is currently under evaluation in cash and equivalents category among its peers.
BIO Fundamentals
| Return On Equity | 0.0769 | |||
| Return On Asset | 0.0347 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 75.36 M | |||
| Shares Outstanding | 10.21 M | |||
| Shares Owned By Institutions | 7.09 % | |||
| Price To Book | 1.52 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 33.46 M | |||
| Gross Profit | 11.99 M | |||
| EBITDA | 3.97 M | |||
| Net Income | 689.38 K | |||
| Cash And Equivalents | 361.07 K | |||
| Total Debt | 26.32 M | |||
| Book Value Per Share | 3.19 X | |||
| Cash Flow From Operations | 3.3 M | |||
| Earnings Per Share | 0.24 X | |||
| Target Price | 6.6 | |||
| Number Of Employees | 150 | |||
| Beta | 0.53 | |||
| Market Capitalization | 52.68 M | |||
| Total Asset | 81.12 M | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 81.12 M |
About BIO UV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIO UV Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIO UV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO UV Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BIO Stock Analysis
When running BIO UV's price analysis, check to measure BIO UV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO UV is operating at the current time. Most of BIO UV's value examination focuses on studying past and present price action to predict the probability of BIO UV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO UV's price. Additionally, you may evaluate how the addition of BIO UV to your portfolios can decrease your overall portfolio volatility.